Constraint-Induced Movement Therapy in Acute Stroke Nursing: Timing, Safety, Motor Recovery, and Nurse-Facilitated Implementation
- 1Woodlands Hospital Singapore
- 2National Veteran General Hospital
- 3Kaohsiung Medical University Hospital
Abstract
Constraint-induced movement therapy (CIMT) is an established upper-limb rehabilitation approach after stroke, but its initiation during the acute phase raises unresolved questions about treatment dose, eligibility, safety, and delivery across multidisciplinary stroke units. This evidence-informed narrative review critically examines randomized trials, systematic reviews, meta-analyses, and clinical guidance relevant to CIMT and modified CIMT (mCIMT), emphasizing nurse-facilitated integration into acute stroke care. Publications first available on or before 30 June 2026 were identified from PubMed, ScienceDirect, publisher pages, citations, and evidence syntheses; authenticated Scopus/Web of Science searches and exhaustive screening were not performed. Stroke phases were distinguished using consensus definitions (acute: days 1–7; early subacute: day 7 to 3 months). Early pilot trials suggested feasibility in selected patients; however, the VECTORS randomized trial found no advantage of dose-matched CIMT over conventional training and less 90-day motor improvement after a high-intensity very-early protocol. Later-phase trials and inpatient meta-analyses support upper-limb improvements in selected populations, although certainty and direct applicability to the first week after stroke remain limited. A 2026 trial of mCIMT combined with a dynamic orthosis is promising but cannot establish general acute-phase safety. Nursing priorities include monitoring neurological and physiological stability, supporting meaningful graded practice, preventing falls and fatigue, promoting adherence, and documenting real-world arm use alongside therapist-led goals. CIMT should be individualized and embedded in multidisciplinary rehabilitation rather than delivered as an unsupervised restraint intervention. Prospective trials must establish optimal timing, dose, safety, and the independent contribution of nurse-facilitated delivery.
Related
- Evaluating the effectiveness of the eHealth-faciLitated SMILe–integrated care model on treatment burden, quality of life and graft-versus-host disease after allogeneic stem cell transplantation: results of two European randomized controlled implementation studies
- Rhythmic dance interventions and dance/movement therapy for depression and anxiety: a structured narrative review of clinical evidence, candidate mechanisms, and implementation considerations
- Exploring factors influencing enhanced recovery after surgery implementation in tertiary hospitals using a DEMATEL–ISM mixed methods approach
- Health4Life: a digital intervention to promote healthy diet and movement behaviours from the start of life: protocol for a hybrid effectiveness-implementation study.
- Sensor-based measurement of fear avoidance and movement patterns of healthy individuals with mechanically induced lower back pain during movement tasks: Study protocol for an experimental non-interventional study
BibTeX
@article{mordiffi2026constraintinduced,
title = {{Constraint-Induced Movement Therapy in Acute Stroke Nursing: Timing, Safety, Motor Recovery, and Nurse-Facilitated Implementation}},
author = {Faiz Mordiffi and Sun-Sheng Feng and Pei-Tsan Lee},
journal = {South East Asia Nursing Research},
year = {2026},
month = oct,
doi = {10.26714/seanr.8.3.2026.162-173},
url = {https://doi.org/10.26714/seanr.8.3.2026.162-173},
note = {CC BY},
}
RIS
TY - JOUR
TI - Constraint-Induced Movement Therapy in Acute Stroke Nursing: Timing, Safety, Motor Recovery, and Nurse-Facilitated Implementation
AU - Faiz Mordiffi
AU - Sun-Sheng Feng
AU - Pei-Tsan Lee
PY - 2026
DA - 2026/10/01
JO - South East Asia Nursing Research
DO - 10.26714/seanr.8.3.2026.162-173
UR - https://doi.org/10.26714/seanr.8.3.2026.162-173
AB - Constraint-induced movement therapy (CIMT) is an established upper-limb rehabilitation approach after stroke, but its initiation during the acute phase raises unresolved questions about treatment dose, eligibility, safety, and delivery across multidisciplinary stroke units. This evidence-informed narrative review critically examines randomized trials, systematic reviews, meta-analyses, and clinical guidance relevant to CIMT and modified CIMT (mCIMT), emphasizing nurse-facilitated integration into acute stroke care. Publications first available on or before 30 June 2026 were identified from PubMed, ScienceDirect, publisher pages, citations, and evidence syntheses; authenticated Scopus/Web of Science searches and exhaustive screening were not performed. Stroke phases were distinguished using consensus definitions (acute: days 1–7; early subacute: day 7 to 3 months). Early pilot trials suggested feasibility in selected patients; however, the VECTORS randomized trial found no advantage of dose-matched CIMT over conventional training and less 90-day motor improvement after a high-intensity very-early protocol. Later-phase trials and inpatient meta-analyses support upper-limb improvements in selected populations, although certainty and direct applicability to the first week after stroke remain limited. A 2026 trial of mCIMT combined with a dynamic orthosis is promising but cannot establish general acute-phase safety. Nursing priorities include monitoring neurological and physiological stability, supporting meaningful graded practice, preventing falls and fatigue, promoting adherence, and documenting real-world arm use alongside therapist-led goals. CIMT should be individualized and embedded in multidisciplinary rehabilitation rather than delivered as an unsupervised restraint intervention. Prospective trials must establish optimal timing, dose, safety, and the independent contribution of nurse-facilitated delivery.
SN - 2685-032X
ER -